User:Lydiadye-stonebridge/CMRO
Current Medical Research and Opinion (CMRO) [1][edit]
-
Current Medical Research and Opinion
Editorial scope[edit]
Current Medical Research and Opinion is a MEDLINE-indexed international peer-reviewed journal for the rapid publication of original research on new and existing drugs, drug-delivery devices and therapies. The journal publishes contributions in the form of editorial commentary, reviews, brief reports and full-length articles.[1]
Current Medical Research and Opinion is published by Informa Pharmaceutical Sciences, a division of Informa plc. The journal is edited by Dimitri P Mikhailidis, Reader and Hon. Consultant, Head of Clinical Biochemistry Dept, Royal Free Hospital and University College London Medical School.[2]
The journal, first published in 1972, has a 2007 Impact Factor of 2.962[3]. CMRO is published continuously online and 12 times per year in print.
Core therapeutic areas[edit]
- Cardiovascular medicine and dyslipidaemia
- Diabetes and metabolic syndrome
- Osteoporosis and musculoskeletal disorders
- Anaemia and haematology
- Pain and analgesia
- Respiratory medicine
- Psychopharmacology and degenerative disorders
- Anaemia and haematology
- Oncology
Citations of CMRO within Wikipedia[edit]
- Treatment of multiple sclerosis
- Treatment of schizophrenia
- Hepatic encephalopathy
- Fibromyalgia
- Thermophobic
- Escitalopram
- Metaclazepam
- Pizotifen
- Dezocine
- Clozapine
- Denopamine
- Sertraline
- Zomepirac
- Fipexide
- ^ Notes to Contributors, http://www.informapharmascience.com
- ^ Current Medical Research and Opinion, Vol 24 No 12
- ^ Thomson ISI Journal Citation Reports 2008)®